BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23338555)

  • 1. Prostate cancer disease severity and country of origin among black men in the United States.
    Fedewa SA; Jemal A
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):176-80. PubMed ID: 23338555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen, sex steroid hormones, and the insulin-like growth factor axis in U.S.-born, Jamaican, and Haitian black men: a pilot study.
    Chen AC; MacChia RJ; Conway F; Magai C; Desai M; Neugut AI
    Urology; 2004 Sep; 64(3):522-7. PubMed ID: 15351583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Prognostic Factors Among Asian Patients Born in the US Compared to Those Born Abroad.
    Xu J; Goodman M; Jemal A; Fedewa SA
    J Immigr Minor Health; 2015 Jun; 17(3):625-31. PubMed ID: 24748076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
    Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
    J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
    Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
    Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
    Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
    Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation of prostate cancer in black South Africans.
    Tindall EA; Monare LR; Petersen DC; van Zyl S; Hardie RA; Segone AM; Venter PA; Bornman MS; Hayes VM
    Prostate; 2014 Jun; 74(8):880-91. PubMed ID: 24723425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.
    Mahal BA; Yang DD; Wang NQ; Alshalalfa M; Davicioni E; Choeurng V; Schaeffer EM; Ross AE; Spratt DE; Den RB; Martin NE; Mouw KW; Orio PF; Choueiri TK; Taplin ME; Trinh QD; Feng FY; Nguyen PL
    Eur Urol; 2018 Aug; 74(2):146-154. PubMed ID: 29478736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of grade progression in patients who harboured Gleason 3 + 3.
    Sampurno F; Earnest A; Millar J; Frydenberg M; Murphy D; Delprado W; Evans S
    World J Urol; 2017 Nov; 35(11):1689-1699. PubMed ID: 28500489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Medhanie GA; Fedewa SA; Adissu H; DeSantis CE; Siegel RL; Jemal A
    Cancer; 2017 Aug; 123(16):3116-3124. PubMed ID: 28407201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique Features of Prostate Cancer in African American and West Indian Patients Including Diagnosis of High Grade Cancers Using Only Elevated Serum Levels of Prostate Specific Antigen.
    Seydafkan S; Michl J; Pincus MR
    Ann Clin Lab Sci; 2020 Jul; 50(4):504-511. PubMed ID: 32826248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
    Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
    J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is prostate cancer different in black men? Answers from 3 natural history models.
    Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R
    Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
    Caster JM; Falchook AD; Hendrix LH; Chen RC
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.